Medical University of South Carolina
Charleston, South Carolina, 29425, United States
NCT Number: NCT02619409
Bupivacaine spinal is commonly performed as the primary anesthetic for orthopedic procedures. In some cases the duration of the block is inadequate. An epinephrine wash is sometimes performed to prolong the duration of the block. The epinephrine wash may prolong the duration of the block, and if it does, to what extent?
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Charleston, South Carolina, 29425, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The bupivacaine only group will receive bupivacaine 0.5% 3cc plus sterile saline 0.1cc.
The EPI25 group will receive bupivacaine 0.5% 3cc, epinephrine 1:1000 0.025cc, and sterile saline 0.075cc.
The EPI50 group will receive bupivacaine 0.5% 3cc, epinephrine 1:1000 0.05cc, and sterile saline 0.05cc
The EPI75 group will receive bupivacaine 0.5% 3cc, epinephrine 1:1000 0.075cc, and sterile saline 0.025%.
The EPI100 group will receive bupivacaine 0.5% 3cc, and epinephrine 1:1000 0.1cc.
Time frame: 12 hours
Duration of the sensory block at the T12 dermatome will be assessed in the post operative phase
Time frame: 12 hours
(hip felxion) of the non operative leg
Medical University of South Carolina
Other
Evaluation of the Duration of Bupivacaine Spinal Block as the Primary Anesthetic for Orthopedic Procedures With and Without Epinephrine Wash
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03808155
Arthropathy of Hip, Arthropathy of Knee
Chur, Kanton Graubünden, Switzerland
View Trial DetailsNCT05399043
Arthropathy of Hip, Arthropathy of Knee
Pavia, PV, Italy
View Trial DetailsNCT05338255
Arthropathy of Hip, Arthropathy of Knee
Zaragoza, Spain
View Trial DetailsNCT05470634
Arthropathy of Hip, Arthropathy of Knee
Saint-Pierre, Reunion
View Trial Details